INS and type 2 diabetes mellitus: Because there is altered energy metabolism and dysfunctional insulin signaling, the accumulation of metabolic substrates produced by hyperlipidemia and hyperglycemia in the chronic stages of TD1M and T2DM can lead to the inhibition of AMPK activity with the consequent inhibition of autophagic flow.